Olga Aleynikova

648 total citations
25 papers, 349 citations indexed

About

Olga Aleynikova is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Olga Aleynikova has authored 25 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Olga Aleynikova's work include Acute Lymphoblastic Leukemia research (6 papers), Cancer Genomics and Diagnostics (4 papers) and BRCA gene mutations in cancer (3 papers). Olga Aleynikova is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Cancer Genomics and Diagnostics (4 papers) and BRCA gene mutations in cancer (3 papers). Olga Aleynikova collaborates with scholars based in Canada, Belarus and Russia. Olga Aleynikova's co-authors include Mark Basik, Saima Hassan, Cristiano Ferrario, Luca Cavallone, Patricia N. Tonin, Catherine Chabot, Aline Mamo, Marc-André Déry, Andréa C. LeBlanc and Josie Ursini‐Siegel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Olga Aleynikova

23 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Aleynikova Canada 10 216 108 86 74 64 25 349
Alexandra E. Gylfe Finland 10 201 0.9× 111 1.0× 148 1.7× 104 1.4× 67 1.0× 14 334
Stephanie K. Guest United Kingdom 7 323 1.5× 168 1.6× 65 0.8× 59 0.8× 44 0.7× 7 429
Chiara Pesenti Italy 14 175 0.8× 105 1.0× 58 0.7× 130 1.8× 66 1.0× 24 405
Chi Wai Wong Hong Kong 7 303 1.4× 130 1.2× 96 1.1× 57 0.8× 44 0.7× 12 447
Agnieszka Pawlaczek Poland 9 195 0.9× 89 0.8× 39 0.5× 75 1.0× 66 1.0× 19 413
TaeJeong Oh South Korea 10 210 1.0× 120 1.1× 75 0.9× 97 1.3× 28 0.4× 14 385
Hae Yoen Jung South Korea 11 183 0.8× 78 0.7× 64 0.7× 58 0.8× 22 0.3× 20 309
Junmei Hao China 6 193 0.9× 104 1.0× 62 0.7× 105 1.4× 29 0.5× 14 311
Adriana Puma Italy 12 141 0.7× 93 0.9× 45 0.5× 60 0.8× 39 0.6× 22 452
Michal Vočka Czechia 11 144 0.7× 141 1.3× 50 0.6× 98 1.3× 68 1.1× 56 349

Countries citing papers authored by Olga Aleynikova

Since Specialization
Citations

This map shows the geographic impact of Olga Aleynikova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Aleynikova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Aleynikova more than expected).

Fields of papers citing papers by Olga Aleynikova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Aleynikova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Aleynikova. The network helps show where Olga Aleynikova may publish in the future.

Co-authorship network of co-authors of Olga Aleynikova

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Aleynikova. A scholar is included among the top collaborators of Olga Aleynikova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Aleynikova. Olga Aleynikova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aleynikova, Olga, et al.. (2023). The prevalence of rare bleeding disorders among children in the Russian Federation. Pediatric Hematology/Oncology and Immunopathology. 22(1). 78–83.
2.
Wong, Stephanie M., Mark Basik, Jean Francois Boileau, et al.. (2022). Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?. Annals of Surgical Oncology. 29(11). 6660–6668. 11 indexed citations
3.
Aleynikova, Olga, Л. Г. Фечина, А. М. Попов, et al.. (2021). Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience. Pediatric Hematology/Oncology and Immunopathology. 20(1). 14–26. 1 indexed citations
4.
Aloyz, Raquel, et al.. (2021). Can high Ki67 predict distant recurrence in early-stage breast cancer with low Oncotype Dx score?. Journal of Clinical Oncology. 39(15_suppl). e12561–e12561. 4 indexed citations
5.
Elkholi, Islam E., Somayyeh Fahiminiya, Suzanna L. Arcand, et al.. (2021). Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. Scientific Reports. 11(1). 2409–2409. 4 indexed citations
6.
Elkrief, Arielle, Luca A. Petruccelli, Caroline Rousseau, et al.. (2021). Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology. BMJ Open Quality. 10(1). e000934–e000934. 5 indexed citations
7.
Wang, Yifan, et al.. (2019). Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review. BMC Gastroenterology. 19(1). 103–103. 11 indexed citations
8.
Попов, А. М., Yulia Olshanskaya, Olga Aleynikova, et al.. (2018). The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience. Terapevticheskii arkhiv. 90(7). 37–50. 2 indexed citations
9.
10.
Zborovskaya, A., et al.. (2017). Clinical significance of polymorphism of thiopurine methyltransferase gene in children with acute lymphoblastic leukemia during programmed therapy. Russian Journal of Pediatric Hematology and Oncology. 4(2). 78–84. 1 indexed citations
11.
12.
Aleynikova, Olga, et al.. (2016). The p53 status can influence the role of Sam68 in tumorigenesis. Oncotarget. 7(44). 71651–71659. 5 indexed citations
13.
Aleynikova, Olga, et al.. (2016). The role and place of haemopoietic stem cell transplantation in treatment of acute myeloid leukemia in children. A Belarus experience. Pediatric Hematology/Oncology and Immunopathology. 15(4). 57–65.
14.
Cavallone, Luca, Aline Mamo, Catherine Chabot, et al.. (2015). The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Research. 75(20). 4351–4363. 41 indexed citations
15.
Blouin, Marie‐José, Miguel Bazile, Elena Birman, et al.. (2015). Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia. Breast Cancer Research and Treatment. 149(3). 577–585. 15 indexed citations
16.
Aleynikova, Olga, et al.. (2014). Mesenchymal Bone Marrow-derived Stem Cells Transplantation in Patients with HCV Related Liver Cirrhosis. Journal of Clinical and Translational Hepatology. 2(4). 217–21. 17 indexed citations
17.
Hartley, Taila, Luca Cavallone, Nelly Sabbaghian, et al.. (2014). Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada. Hereditary Cancer in Clinical Practice. 12(1). 19–19. 18 indexed citations
18.
Buchanan, Marguerite, Olga Aleynikova, Dongsheng Tu, et al.. (2013). RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial. PLoS ONE. 8(12). e81740–e81740. 8 indexed citations
19.
Mamo, Aline, Luca Cavallone, Şükrü Tüzmen, et al.. (2011). An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene. 31(16). 2090–2100. 100 indexed citations
20.
Chami, Rose, et al.. (2010). Xanthogranulome juvénile de la cavité nasale. Annales de Pathologie. 30(5). 374–377. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra E. Gylfe Breakdown of academic impact, for papers by Stephanie K. Guest Breakdown of academic impact, for papers by Chiara Pesenti Breakdown of academic impact, for papers by Chi Wai Wong Breakdown of academic impact, for papers by Agnieszka Pawlaczek Breakdown of academic impact, for papers by TaeJeong Oh Breakdown of academic impact, for papers by Hae Yoen Jung Breakdown of academic impact, for papers by Junmei Hao Breakdown of academic impact, for papers by Adriana Puma Breakdown of academic impact, for papers by Michal Vočka
Rankless by CCL
2026